| Product Code: ETC12541615 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel continued to import lipid nanoparticles primarily from Switzerland, UK, Belgium, USA, and Germany. The market remained competitive with a low concentration level, indicating a diverse range of suppliers. Despite a slight decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -2.14%, the year-on-year growth rate in 2024 improved slightly to -0.41%. This data suggests a stable market for lipid nanoparticles imports in Israel, with opportunities for sustained growth and market resilience.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Lipid Nanoparticles Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Lipid Nanoparticles Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Lipid Nanoparticles Market - Industry Life Cycle |
3.4 Israel Lipid Nanoparticles Market - Porter's Five Forces |
3.5 Israel Lipid Nanoparticles Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Israel Lipid Nanoparticles Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Lipid Nanoparticles Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Lipid Nanoparticles Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Israel Lipid Nanoparticles Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for targeted drug delivery systems in pharmaceuticals. |
4.2.2 Advancements in nanotechnology and the development of lipid nanoparticles for various applications. |
4.2.3 Growing research and development activities in the field of nanomedicine. |
4.2.4 Favorable government initiatives and investments in healthcare and biotechnology sectors. |
4.3 Market Restraints |
4.3.1 High cost associated with the development and production of lipid nanoparticles. |
4.3.2 Regulatory challenges and stringent approval processes for lipid nanoparticle-based products. |
4.3.3 Limited awareness and adoption of lipid nanoparticles in certain medical applications. |
5 Israel Lipid Nanoparticles Market Trends |
6 Israel Lipid Nanoparticles Market, By Types |
6.1 Israel Lipid Nanoparticles Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Lipid Nanoparticles Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Israel Lipid Nanoparticles Market Revenues & Volume, By Solid Lipid Nanoparticles, 2021 - 2031F |
6.1.4 Israel Lipid Nanoparticles Market Revenues & Volume, By Nanostructured Lipid Carriers, 2021 - 2031F |
6.1.5 Israel Lipid Nanoparticles Market Revenues & Volume, By Liposomes, 2021 - 2031F |
6.2 Israel Lipid Nanoparticles Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Lipid Nanoparticles Market Revenues & Volume, By Drug Delivery Systems, 2021 - 2031F |
6.2.3 Israel Lipid Nanoparticles Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.4 Israel Lipid Nanoparticles Market Revenues & Volume, By Vaccines, 2021 - 2031F |
6.2.5 Israel Lipid Nanoparticles Market Revenues & Volume, By Cosmetics, 2021 - 2031F |
6.3 Israel Lipid Nanoparticles Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Lipid Nanoparticles Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Israel Lipid Nanoparticles Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 Israel Lipid Nanoparticles Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Israel Lipid Nanoparticles Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Lipid Nanoparticles Market Revenues & Volume, By Lipid-Based Nanocarriers, 2021 - 2031F |
6.4.3 Israel Lipid Nanoparticles Market Revenues & Volume, By Liposome, 2021 - 2031F |
7 Israel Lipid Nanoparticles Market Import-Export Trade Statistics |
7.1 Israel Lipid Nanoparticles Market Export to Major Countries |
7.2 Israel Lipid Nanoparticles Market Imports from Major Countries |
8 Israel Lipid Nanoparticles Market Key Performance Indicators |
8.1 Research and development expenditure in nanomedicine. |
8.2 Number of patents filed for lipid nanoparticle technologies. |
8.3 Rate of adoption of lipid nanoparticles in clinical trials. |
8.4 Investment in infrastructure for lipid nanoparticle production. |
8.5 Number of collaborations and partnerships in the lipid nanoparticles market. |
9 Israel Lipid Nanoparticles Market - Opportunity Assessment |
9.1 Israel Lipid Nanoparticles Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Israel Lipid Nanoparticles Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Lipid Nanoparticles Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Lipid Nanoparticles Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Israel Lipid Nanoparticles Market - Competitive Landscape |
10.1 Israel Lipid Nanoparticles Market Revenue Share, By Companies, 2024 |
10.2 Israel Lipid Nanoparticles Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |